CLINICAL_TRIALS
trial_result
· 2026-01-16
Clinical Trial Update: Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML [Phase 1]
Summary
A Phase 1 clinical trial is evaluating venetoclax in combination with intensive induction and consolidation chemotherapy in treatment-naïve acute myeloid leukem…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING